Skip to main content

Split-Screen Recovery, North-South Divide, Price Alert: Eco Day

The economic rebound powering the S&P 500 Index has skipped large swaths of Main Street, with small businesses waiting to join the partyThe economic divide between China's prospering southern regions and lagging northern areas will continue to widen in coming yearsThe world's worst Covid-19 outbreak in India risks fanning price pressures, threatening to limit the central bank's options to support the economy. Over in the U.S., a bond-market gauge of inflation expectations soared to the highest level in eight yearsThe European Commission is seeking powers to levy fines or block deals by foreign state-owned companies in a thinly veiled response to the growing economic threat posed by ChinaSouth Korea's consumer sentiment strengthened in April for a fourth straight month as the economic recovery powered aheadTiff Macklem said he remains committed to the Bank of Canada's 2% inflation target, even as the goal is likely to temporarily overshotThe Fed will stick to its policy glide path at its meeting Wednesday, Bloomberg Economics predicted in this wrap of its latest researchDrama around one of China's biggest bad-debt managers highlights an urgent need to simplify oversight of the nation's financial systemThe head of the WTO raised an alarm about the credibility of the multilateral trading system, urging leaders to act fast to bolster the global economy with steps like fairer vaccine distributionPresident Joe Biden's team is planning to forgo an expansion of the estate tax in tax-hike proposals. It's not the rich who should be afraid of the tax plans. It's the really rich who should be nervousSingapore officials trying to digitize the economy are targeting tricky holdouts: elderly vendors who run the country's famed hawker stallsSaudi Arabia's unemployment will fall below 11% this year as the kingdom's economy goes through a "V-shaped" recovery, Crown Prince Mohammed Bin Salman said in a local TV interviewJamie Dimon is sending a message to his fellow Wall Street chiefs: It's time to bring employees back to the office Read More

from Financial Post https://ift.tt/3eR662n
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more